226 related articles for article (PubMed ID: 38240686)
21. Identification of an individualized RNA binding protein-based prognostic signature for diffuse large B-cell lymphoma.
Xie Y; Luo X; He H; Pan T; He Y
Cancer Med; 2021 Apr; 10(8):2703-2713. PubMed ID: 33749163
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
23. Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma.
Wang L; Yuan W; Li L; Shen Z; Geng Q; Zheng Y; Zhao J
J Immunol Res; 2022; 2022():9544827. PubMed ID: 35983077
[TBL] [Abstract][Full Text] [Related]
24. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma.
Mu S; Shi D; Ai L; Fan F; Peng F; Sun C; Hu Y
Front Immunol; 2021; 12():732006. PubMed ID: 34745101
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a [
Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
[TBL] [Abstract][Full Text] [Related]
26. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
27. A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment.
Cui Y; Leng C
Front Cell Dev Biol; 2023; 11():1070777. PubMed ID: 36755971
[No Abstract] [Full Text] [Related]
28. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
29. A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma.
Zhang Z; Zhao C; Yang S; Lu W; Shi J
Lipids Health Dis; 2024 Jan; 23(1):20. PubMed ID: 38254162
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China.
Li X; Xu Q; Gao C; Yang Z; Li J; Sun A; Wang Y; Lei H
Ann Hematol; 2023 Dec; 102(12):3465-3475. PubMed ID: 37615680
[TBL] [Abstract][Full Text] [Related]
31. Construction of a DLBCL Prognostic Signature Based on Tumor Microenvironment.
Wang G; Qiu C; Zhang C; Hou S; Zhang Q
Expert Rev Hematol; 2021 Jul; 14(7):679-686. PubMed ID: 34139942
[TBL] [Abstract][Full Text] [Related]
32. An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma.
Zhou X; He YZ; Liu D; Lin CR; Liang D; Huang R; Wang L
Front Genet; 2022; 13():862179. PubMed ID: 35846146
[No Abstract] [Full Text] [Related]
33. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
34.
Sun J; Zhu X; Zhao Y; Zhou Q; Qi R; Liu H
Pharmgenomics Pers Med; 2021; 14():397-408. PubMed ID: 33833551
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma.
Pan YB; Wang W; Cai HK; Zhang J; Teng Y; Xue J; Zhu M; Luo WD
Front Genet; 2022; 13():911443. PubMed ID: 36035126
[No Abstract] [Full Text] [Related]
37. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
Wang J; Peng H; Zhang G; Yan W
Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
[TBL] [Abstract][Full Text] [Related]
40. A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma.
Zhao Z; Shen X; Zhao S; Wang J; Tian Y; Wang X; Tang B
Aging (Albany NY); 2023 Nov; 15(22):12927-12951. PubMed ID: 37976136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
